Why the study?
Does the timing of initial administration of low-molecular-weight heparin prophylaxis affect deep vein thrombosis prevention in patients following elective hip arthroplasty?
Does the timing of initial administration of low-molecular-weight heparin prophylaxis affect deep vein thrombosis prevention in patients following elective hip arthroplasty?
Delayed initiation of low-molecular-weight heparin prophylaxis after elective hip arthroplasty reduces antithrombotic effectiveness without providing a safety advantage.
Answers are grounded in this paper and cite their sources.
Recommend early LMWH initiation after hip arthroplasty; strengthens guideline recommendations on prophylaxis timing.
The timing of initiating low-molecular-weight heparin significantly influences antithrombotic effectiveness. The practice of delayed initiation of low-molecular-weight heparin prophylaxis results in suboptimal antithrombotic effectiveness without a substantive safety advantage.
No takes yet. Share an insight, caveat, or question.
Hull et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: